Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
21 studies found for:    Open Studies | "Liver Cirrhosis, Biliary"
Show Display Options
Rank Status Study
1 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
2 Recruiting Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Genetic: Genetic Analysis
3 Recruiting Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Bezafibrate;   Drug: Ursodeoxycholic Acid;   Drug: Placebo (for Bezafibrate)
4 Recruiting Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
5 Recruiting Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
6 Recruiting Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
7 Recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
8 Recruiting Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
9 Recruiting Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
10 Recruiting Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients
Condition: Primary Biliary Cirrhosis
Interventions: Other: Clinic visit;   Other: Baseline visit
11 Not yet recruiting A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Saroglitazar magnesium 2 mg;   Drug: Saroglitazar magnesium 4 mg;   Drug: Placebo Oral Tablet
12 Recruiting MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: MBX-8025 5 mg Capsule;   Drug: MBX-8025 10 mg Capsule;   Drug: MBX-8025 25 mg Capsule
13 Recruiting Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Intervention:
14 Recruiting A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Condition: Biliary Cirrhosis, Primary
Intervention:
15 Recruiting sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
Conditions: Primary Biliary Cirrhosis;   Liver Inflammation
Intervention: Other: Blood samples, fibroscan and questionaires
16 Recruiting sCD163 in PBC Patients - Assessment of Treatment Response
Conditions: Primary Biliary Cirrhosis;   Liver Inflammation;   Ursodeoxycholic Acid
Interventions: Other: Blood samples;   Device: Fibroscan;   Other: Questionnaires;   Biological: Liver biopsy
17 Recruiting Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
Conditions: Hepatitis, Autoimmune;   Cholangitis;   Liver Cirrhosis, Biliary;   Cholestasis
Interventions: Drug: Ursodeoxycholic acid combination of immunosuppressive agents;   Drug: Ursodeoxycholic Acid
18 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
19 Recruiting Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Conditions: Cholangitis;   Liver Cirrhosis, Biliary;   Cholestasis;   Liver Diseases;   Liver Cirrhosis;   Bile Duct Diseases
Intervention:
20 Recruiting A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cholangitis
Interventions: Drug: LJN452;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.